PWA
MESO

Physician Wealth Advisors’s Mesoblast MESO Stock Holding History

Physician Wealth Advisors’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49
Closed -$884 – 2173
2025
Q4 		$884 Hold
49
– – ﹤0.01% 1678
2025
Q3 		$790 Sell
49
-8
-14% -$117 ﹤0.01% 1696
2025
Q2 		$621 Buy
+57
New +$639 ﹤0.01% 1651

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Physician Wealth Advisors's MESO Position: Q1 2026 in Review

Physician Wealth Advisors sold out of Mesoblast (MESO) in Q1 2026, closing a stake of 49 shares — an estimated $884 sold.

Physician Wealth Advisors first reported a position in MESO in Q2 2025 and held it in 3 quarters. The position peaked at $884 in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Physician Wealth Advisors reported no remaining Mesoblast position as of Q1 2026 after selling out during the quarter.
  • Physician Wealth Advisors sold 49 Mesoblast shares in Q1 2026, an estimated $884.
  • Physician Wealth Advisors first reported a position in Mesoblast in Q2 2025 and held it in 3 quarters.
  • Physician Wealth Advisors's Mesoblast position peaked at $884 in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.